Some studies have shown that the level of serum OPG is associated with metabolic diseases, such as NAFLD.78–80 However, the relationship between the OPG or OPG/RANK/RANKL signaling system and metabolic disorders is still unclear. Here, TNFRSF11B is linked to metabolic dysfunction-associated steatotic liver disease.